- Global Pharma News & Resources

Red Blood Cell Exchange System: Fenwal Amicus

Fenwal Amicus Red Blood Cell Exchange (RBCx) system won clearance from the FDA. The news was announced recently by Bad Homburg, Germany based company Fresenius Kabi, which has developed the system in the first place.

The device works to replace a patientrsquo;s blood cells with another fluid after automatically removing the blood cells. It is going to be especially useful in cases where the patient is suffering from sickle cell disease. In accordance with the requirement of the patient and blood centers that stock up on platelet and plasma fluids, the system can perform functions that include exchanging, depleting/ exchanging and depleting procedures.

According to the company, the system got approval in Europe almost three years ago. The company also added that in the United States it is indicated for therapeutic plasma exchange (TPE), mononuclear cell (MNC) collection and platelet collection.

Integrated weight scales that measure and compare how much fluid is removed and how much is delivered to the patient have been incorporated in the Fenwal Amicus. Additionally an optical sensor that monitors the red cell separation process, helping the system to make sure itrsquo;s doing the job correctly also features in the Fenwal Amicus system.

Editor Details

Last Updated: 20-Mar-2019